**Question:** This patient with diffuse, nonencapsulated fatty deposits is most likely to have a history of which one of the following?

A. Hypothyroidism
B. Polycystic Ovary Syndrome (PCOS)
C. Cirrhosis
D. Hyperlipidemia

**Correct Answer:** D. Hyperlipidemia

**Core Concept:** Fatty liver or steatosis is a condition characterized by the accumulation of excess triglycerides in hepatocytes, leading to hepatomegaly and non-specific symptoms. Fatty liver can be classified as primary (idiopathic or genetic) or secondary (related to other underlying conditions).

**Why the Correct Answer is Right:** In this case, the patient has diffuse, nonencapsulated fatty deposits, which indicates secondary fatty liver. Among the given options, hyperlipidemia (elevated plasma lipids) is the most common cause of secondary fatty liver.

**Why Each Wrong Option is Incorrect:**

A. Hypothyroidism: Fatty liver is less common in hypothyroidism, and the liver function tests are typically normal.
B. Polycystic Ovary Syndrome (PCOS): PCOS is associated with insulin resistance and polycystic ovaries, not fatty liver.
C. Cirrhosis: Cirrhosis is a chronic liver disease characterized by fibrosis and nodular regeneration, not diffuse fatty deposits.

**Why Each Wrong Option is Incorrect:**

A. Hypothyroidism: Fatty liver is less common in hypothyroidism, and liver function tests are typically normal.
B. Polycystic Ovary Syndrome (PCOS): PCOS is associated with insulin resistance and polycystic ovaries, not fatty liver.
C. Cirrhosis: Cirrhosis is a chronic liver disease characterized by fibrosis and nodular regeneration, not diffuse fatty deposits.

**Clinical Pearl:** While the correct answer is hyperlipidemia, it is essential to consider other conditions like alcohol intake, obesity, or medications as potential causes of fatty liver. Early identification and management of these underlying conditions can prevent progression to steatohepatitis, fibrosis, and cirrhosis.